Skip to main content
CAMBRIDGE COGNITION HOLDINGS PLC logo

CAMBRIDGE COGNITION HOLDINGS PLC — Investor Relations & Filings

Ticker · COG ISIN · GB00B8DV9647 LEI · 213800SZKDIN122EPA96 IL Professional, scientific and technical activities
Open in API
Filings indexed 368 across all filing types
Latest filing 2022-09-01 Regulatory Filings
Country GB United Kingdom
Listing IL COG

About CAMBRIDGE COGNITION HOLDINGS PLC

https://www.cambridgecognition.com/

Cambridge Cognition Holdings PLC is a neuroscience technology company that develops and markets digital solutions to assess brain health. The company provides an end-to-end platform for Central Nervous System (CNS) clinical trials, featuring a suite of scientifically validated digital cognitive assessments. Its technologies include touchscreen tests, voice analysis, electronic questionnaires, and high-frequency testing, which can be deployed both in-clinic and remotely for decentralized trials. These tools are utilized by pharmaceutical companies, academic research institutions, and healthcare professionals to accelerate drug development and enhance the understanding and treatment of conditions affecting brain health. With over 30 years of scientific validation, its assessments are recognized for their sensitivity in detecting subtle cognitive changes across numerous therapeutic areas.

Recent filings

Filing Released Lang Actions
£2.2m neurodegenerative disease trial contract
Regulatory Filings Classification · 99% confidence The document starts with 'RNS Number : 8231X' and is dated '01 September 2022'. It announces a significant business event: winning a £2.2 million contract for cognitive assessments. The text concludes with boilerplate information referencing 'RNS, the news service of the London Stock Exchange' and the FCA. This structure is characteristic of a general regulatory news service announcement, which is the definition of the RNS category. It is not a full financial report (10-K, IR), an earnings release (ER), or a specific shareholder vote result (DVA). Since it is a general regulatory announcement that doesn't fit the more specific categories like DIV, DIRS, or MANG, the appropriate classification is Regulatory Filings (RNS). The document length is relatively short (4415 chars) and functions as an announcement, supporting the RPA/RNS distinction, but RNS is the most precise fit for LSE regulatory news.
2022-09-01 English
Alzheimer’s Disease Validation for NeuroVocalix
Legal Proceedings Report Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory or news announcement. The content announces a collaboration between Cambridge Cognition and the University of Oxford regarding the ISAP study, focusing on cognitive assessments for Alzheimer's disease. This is a specific business development update, not a formal financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). It is a general announcement distributed via the RNS system, specifically noted as being distributed by 'Reach, the non-regulatory press release distribution service of RNS'. Since it is a general, non-standard announcement that doesn't fit the specific categories like ER, CT, or CAP, the most appropriate fallback category is Regulatory Filings (RNS), as it is a general market communication distributed through the RNS platform.
2022-08-17 English
Directorate Change
Board/Management Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number: 8214U) dated August 3, 2022. The title of the announcement is "Directorate Change," and the content explicitly details the appointment of Stephen Symonds as an Executive Director to the Board of Cambridge Cognition Holdings Plc. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-08-03 English
PTSD trials with top 10 pharma company & US DoD
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content announces business developments: securing agreements with the US Department of Defense and a top 10 pharmaceutical company for PTSD trials using cognitive assessment tools. This type of announcement, which details operational news, contract wins, or significant business updates that are not mandatory periodic financial reports (like 10-K or IR) or specific corporate actions (like DIV or SHA), typically falls under the general regulatory announcement category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general, time-sensitive regulatory news service release that doesn't fit a more specific category like ER, CT, or MANG. It is not a full report (10-K, IR), nor is it a proxy statement (DEF 14A) or an earnings release (ER).
2022-07-28 English
Grant of Options
Remuneration Information Classification · 99% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) from Cambridge Cognition Holdings PLC. The core content details the 'Grant of Options' under the Company's Long Term Incentive Plan (LTIP) to Persons Discharging Managerial Responsibilities (PDMRs) and other employees. This involves the issuance of options over ordinary shares, which is a form of capital/financing activity related to employee compensation and share structure. However, the most specific category that covers transactions by directors and executives regarding their holdings or grants related to shares is 'Director's Dealing' (DIRS) or 'Share Issue/Capital Change' (SHA). Since this filing explicitly follows the structure of a 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES' (PDMR notification), it directly aligns with the definition of Director's Dealing (insider trades/transactions). While it involves capital structure (options grant), the primary regulatory focus and disclosure requirement being met here is the insider transaction reporting for PDMRs, making DIRS the most appropriate fit over CAP or SHA.
2022-07-26 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1944 characters) and announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, referencing an RNS Number and the Financial Conduct Authority. It is a specific, time-sensitive operational announcement regarding trading halts/extensions, not a comprehensive financial report (like 10-K or IR) or a standard earnings release (ER). Since it is a regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or MANG, the most appropriate classification is the general regulatory filing fallback category, RNS (Regulatory News Service).
2022-07-22 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.